GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » Big Pharma Split Corp (TSX:PRM.PR.A.PFD) » Definitions » Credit Losses Provision

Big Pharma Split (TSX:PRM.PR.A.PFD) Credit Losses Provision : C$0.00 Mil (As of Dec. 2023)


View and export this data going back to 2017. Start your Free Trial

What is Big Pharma Split Credit Losses Provision?

Big Pharma Split's credit losses provision for the six months ended in Dec. 2023 was C$0.00 Mil. Its credit losses provision for the trailing twelve months (TTM) ended in Dec. 2023 was C$0.00 Mil.

Big Pharma Split Credit Losses Provision Historical Data

The historical data trend for Big Pharma Split's Credit Losses Provision can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Big Pharma Split Credit Losses Provision Chart

Big Pharma Split Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Credit Losses Provision
Get a 7-Day Free Trial - - - - -

Big Pharma Split Semi-Annual Data
Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Credit Losses Provision Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Big Pharma Split Credit Losses Provision Calculation

For each period of operations, banks may reserve a portion of their income to cover the possible non-performing loans. The amount of the Credit Losses Provision is dependent on the management's estimate of the load quality they have. The higher Credit Losses Provision is, the lower banks' reported income in. This does not affect banks' cash flow statement.

Credit Losses Provision for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was C$0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Big Pharma Split (TSX:PRM.PR.A.PFD) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » Big Pharma Split Corp (TSX:PRM.PR.A.PFD) » Definitions » Credit Losses Provision
Comparable Companies
TSX:PWI TSXV:MONT TSX:XTD TSX:MDS.UN TSXV:FW TSXV:TORR TSX:MSRE.UN XCNQ:IDK TSXV:TIE XCNQ:SPLY BLK BX OSTO:INVE A TSX:BN KKR APO BK AMP XSWX:PGHN LSE:III
Traded in Other Exchanges
PRM:Canada
Address
610 Chartwell Road, Suite 204, Oakville, ON, CAN, L6J 4A5
Website
https://www.harvestportfolios.com
Big Pharma Split Corp is a mutual fund corporation. Its investment objective is to provide shareholders with fixed cumulative preferential quarterly cash distributions, and regular monthly cash distributions. The company has a presence in the United States; Switzerland; France and United Kingdom.

Big Pharma Split (TSX:PRM.PR.A.PFD) Headlines

No Headlines